Medical specialists from Moldova, Republic of tagged as investigators in clinical trials studying Lymphoma, Mantle-Cell
Total 1 results
-
Vasile Musteata, MD, PhDSeen in:
- Chisinau, Institute of Oncology, ARENSIA Exploratory Medicine
Trials:- NCT05544019 (Principal Investigator)
Conditions:- Follicular Lymphoma;
- Splenic Marginal Zone Lymphoma;
- Burkitt Lymphoma;
- Plasmablastic Lymphoma;
- Waldenstrom Macroglobulinemia;
- Mantle Cell Lymphoma;
- Chronic Lymphocytic Leukemia;
- Lymphoplasmacytic Lymphoma;
- Non Hodgkin Lymphoma;
- Primary Effusion Lymphoma;
- DLBCL;
- High-grade B-cell Lymphoma;
- Primary Mediastinal Large B Cell Lymphoma;
- Nodal Marginal Zone Lymphoma;
- MALT Lymphoma;
- EBV-Positive DLBCL, Nos;
- ALK-Positive Large B-Cell Lymphoma;
- DLBCL Germinal Center B-Cell Type;
- Primary Cutaneous Follicle Center Lymphoma;
- Mature B-Cell Neoplasm;
- Pediatric-Type Follicular Lymphoma;
- IRF4 Gene Rearrangement;
- T-Cell/Histiocyte Rich Lymphoma;
- Primary Cutaneous Diffuse Large B-Cell Lymphoma;
- HHV8-Positive DLBCL, Nos;
- Duodenal-Type Follicular Lymphoma
Clinical Trials on Lymphoma, Mantle-Cell
-
Northwestern UniversityNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCActive, not recruitingStage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Stage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedStage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
Burzynski Research InstituteWithdrawnRecurrent Mantle Cell Lymphoma | Stage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell LymphomaUnited States
-
Roswell Park Cancer InstituteNational Comprehensive Cancer NetworkCompletedStage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Stage I Mantle Cell Lymphoma | Stage II Contiguous Mantle Cell Lymphoma | Stage II Non-Contiguous Mantle Cell LymphomaUnited States
-
University of WashingtonNational Cancer Institute (NCI); National Comprehensive Cancer NetworkTerminatedRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma | Ann Arbor Stage I Mantle Cell Lymphoma | Ann Arbor Stage II Mantle Cell Lymphoma | Ann Arbor Stage III Mantle Cell Lymphoma | Ann Arbor Stage IV Mantle Cell LymphomaUnited States
-
BeiGeneRecruitingMantle Cell Lymphoma | Relapsed Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma (MCL)United States, China, Israel, Belgium, Poland, Spain, Turkey, Brazil, Italy, Canada, United Kingdom, France, Germany, Argentina, Puerto Rico
-
BeiGeneCompletedRefractory Mantle Cell Lymphoma | Relapsed Mantle Cell LymphomaChina
-
Fondazione Italiana Linfomi - ETSRecruitingRefractory Mantle Cell Lymphoma | Relapsed Mantle Cell LymphomaItaly
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Mantle Cell Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Central Nervous System Lymphoma | Gastric Mantle Cell Lymphoma | Splenic Mantle Cell LymphomaUnited States